A statistically significant difference (p < 0.0001) was observed between the mean preoperative SCF plasma level of the patients with GBM (2.80 ± 1.52 ng/ml) and nonglial tumors (1.41 ± 0.76 ng/ml). This evidence concerns the gene KITLG and glioblastoma.